Human TIM-1 promotes the entry of HTNV and ANDV pseudoviruses 1 0 5
Over the last years, studies have shown that human TIM-1, a protein initially implicated as a of hantaviruses, we explored the possibility that TIM-1 mediates their cell entry. of hantaviruses is the strict biosafety requirements limiting work with these pathogens to 1 1 5 BSL-3 facilities. For our study, we employed vesicular stomatitis virus (VSV)-pseudotypes 1 1 6
we have previously characterized and validated (Torriani, Mayor et al. 2019 the South American ANDV, we used recombinant VSV*ΔG-Luc in which the glycoprotein 1 1 9 (G) gene was deleted and replaced with reporter genes encoding enhanced green fluorescent (Holland, de la Torre et al. 1989) to lower background (Fig. 1A) . Using a similar approach, 1 2 7
we generated pseudoviruses for EBOV and Lassa virus (LASV). The resulting "VSV- work under BSL-2 conditions. 1 3 0
As hantaviruses are transmitted via aerosols (Vaheri, Henttonen et al. 2013 , Vaheri, Strandin tested the ability of anti-TIM-1 antibody to block infection. To do this, we treated A549 cells 1 3 7
with goat anti-TIM-1 polyclonal antibody or normal goat IgG as control, and subsequently To examine whether hTIM-1 enhances hantavirus infection, we took advantage of the human al. 2018) and generated cell lines overexpressing hTIM-1 ( Fig. 2A) . Analysis by direct 1 5 1 fluorescence microscopy revealed that the entry of VSV*ΔG-Luc(HTNV-G) and VSV*ΔG-
Luc(ANDV-G) was facilitated in cells overexpressing hTIM-1 compared to parental HEK293 possibility that hTIM-4 mediates the entry of hantaviruses in macrophages and dendritic cells. The receptor-type tyrosine kinase Axl promotes the entry of ANDV-G 1 8 0
Whereas TIM-1 and TIM-4 directly bind to PS and PE exposed in the viral membrane, virus cells was significantly reduced in presence of anti-hTIM-1 blocking antibody ( Fig. 1 ).
1 8
Conversely, overexpression of hTIM-1 in HEK293 cells, which express low levels of hTIM-1 3 1 9
induces a massive increase in the uptake of HTNV and EBOV pseudovirions, and a more 3 2 0 modest increase in the uptake of ANDV pseudovirions (Fig. 2) . TIM-1 is expressed on cilia of Our data show that the viral usage of hTIM-4 parallels that of hTIM-1, although at a lower 3 2 6 efficiency ( Fig. 3 ). TIM-4 is predominantly expressed in macrophages and subsets of hantaviruses in macrophages and dendritic cells.
We found by antibody perturbation experiments, as well as use of the R428 kinase inhibitor 3 3 1 that the tyrosine receptor kinase Axl, a member of the TAM (Tyro3, Axl, Mer) protein family 3 3 2 could promote entry of ANDV, but not HTNV (Fig. 4 ). This differential receptor use by these receptors mediate apoptotic cell uptake by phagocytes which is critical for lung homeostasis. As we observe that Axl can contribute to the entry of ANDV, lung macrophages could 3 4 2 constitute early targets, a possibility that could be assessed using pulmonary macrophages Using antibody perturbation, we showed that the previously identified hantavirus receptor contributes to HTNV entry in A549 cells ( Fig. 5 ). We also found that HSPG was used by Recently, PCDH1 has been shown to be essential for entry of ANDV into vascular endothelial The viral entry into host cells is mainly determined by the interaction between cellular Zhang et al. 2015), we expect duramycin to inhibit authentic hantaviruses. Indeed we showed 3 5 8 that duramycin is a potent antiviral against pathogenic HTNV with 88% of viral infection that the duramycin-mediated inhibition was greater that the contribution of TIM receptors, into human airway epithelial cells should be further investigated. In sum, our studies provide first evidence for a role of TIM-1 and expand understanding on the viral transmission between natural reservoirs and human host and can lead moreover to new avenues for the development of drugs. Control, South Mimms, UK). Flag-hTim1 (Addgene plasmid # 49207) was a gift from L. Ullrich (Zhang, Knyazev et al. 2008) . Human TIMD4 was obtained from Sino Biological Inc. Abcam. Purified mouse anti-human integrin α vβ3 monoclonal antibody (MAB1976) was 3 9 0 from Millipore. PE-conjugated goat anti-mouse pAb and alexa 647-conjugated goat anti-3 9 1 rabbit pAb were from Invitrogen. The VSV neutralizing antibody I1 (I1 mAb) has been The chemicals included G418 (Promega), R428 (Selleckem), duramycin (Chem Cru), heparan Kit were obtained from Invitrogen. The CellTiter-Glo® Assay System and the ONE-Glo™ 3 9 6
Luciferase Assay System were obtained from Promega (Madison WI). Human lung carcinoma alveolar epithelial (A549) cells, and human embryonic kidney washed twice and resuspended in PBS. Flow cytometry was performed using the BD 4 2 9
Accuri TM C6 (BD Bioscience) flow cytometer. Confluent monolayers of A549 cells were pre-treated with drugs for 30 min at 37°C under 5% 4 5 1 CO 2 , followed by infection with the indicated viruses in presence of the drugs for 1.5 h at with VSV*ΔG-Luc(HTNV-G) and VSV*ΔG-Luc(ANDV-G) at the indicated IU. Infection assessed as in Fig. 1B. (B) Axl contributes to entry of ANDV-G but not HTNV-G 7 2 0 pseudoviruses into A549 cells. A549 cells were blocked with 30 nM of goat anti-Axl pAb, 7 2 1 goat anti-hTIM-1 pAb and control goat IgG for 1 h in the cold. Cells were then infected with 7 2 2 indicated pseudoviruses and shifted to 37 °C. After 90 min, complete medium containing 20 7 2 3 mM ammonium chloride was added, followed by 16 h of incubation. Infection levels were 
